Intra-abdominal Fat Predicts Survival in Pancreatic Cancer

Background Body mass index (BMI) has proven unreliable in predicting survival following pancreaticoduodenectomy for cancer. While measures of intra-abdominal fat correlate with medical and postoperative complications of obesity, the impact of intra-abdominal fat on pancreatic cancer survival is unce...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastrointestinal surgery Vol. 14; no. 11; pp. 1832 - 1837
Main Authors Balentine, Courtney J., Enriquez, Jose, Fisher, William, Hodges, Sally, Bansal, Vivek, Sansgiry, Shubhada, Petersen, Nancy J., Berger, David H.
Format Journal Article
LanguageEnglish
Published New York Springer-Verlag 01.11.2010
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Body mass index (BMI) has proven unreliable in predicting survival following pancreaticoduodenectomy for cancer. While measures of intra-abdominal fat correlate with medical and postoperative complications of obesity, the impact of intra-abdominal fat on pancreatic cancer survival is uncertain. We hypothesized that the quantity of intra-abdominal fat would predict survival following resection of pancreatic cancer. Methods Preoperative CT imaging was used to measure intra-abdominal fat. Cox regression analyses were used to identify independent predictors of survival. Results Sixty-one patients from 2000–2009 underwent pancreaticoduodenectomy for exocrine pancreatic adenocarcinoma. After adjusting for age and perineural invasion status, preoperative BMI did not predict overall survival ( p  < 0.827). Unlike BMI, quartile of intra-abdominal fat predicted survival. Relative to patients with the least intra-abdominal fat (lowest quartile), those with more intra-abdominal fat demonstrated worse overall survival, but in a non-linear fashion. Individuals in the second quartile showed a fourfold increase in likelihood of death (HR 4.018, 95% CI 1.099–14.687, p  < 0.035) relative to the lowest quartile. Patients in the third (HR 2.124, 95% CI 0.278–16.222, p  < 0.468) and fourth quartile (HR 1.354, 95% CI 0.296–6.190, p  < 0.696) also showed greater risk of death. Conclusions Measuring intra-abdominal fat identifies a subset of patients with worse prognosis in pancreatic cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1091-255X
1873-4626
DOI:10.1007/s11605-010-1297-5